{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:06:50Z","timestamp":1770505610633,"version":"3.49.0"},"reference-count":413,"publisher":"Informa UK Limited","issue":"10-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1080\/10826080600846235","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T14:00:06Z","timestamp":1159279206000},"page":"1395-1463","source":"Crossref","is-referenced-by-count":40,"title":["Drug Interactions Between Psychoactive Substances and Antiretroviral Therapy in Individuals Infected With Human Immunodeficiency and Hepatitis Viruses"],"prefix":"10.1080","volume":"41","author":[{"given":"Manuela G.","family":"Neuman","sequence":"first","affiliation":[{"name":"In Vitro Drug Safety and Biotechnology, Toronto, Ontario, Canada"},{"name":"University of Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maristela","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[{"name":"University of Toronto, Ontario, Canada"},{"name":"Addiction Research Institute, Zurich, Switzerland"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31249-4"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)32545-1"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856060-00014"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00024-2"},{"key":"e_1_3_2_6_1","volume-title":"Division of AIDS","author":"AIDS Clinical Trial Group Criteria","year":"1992","unstructured":"AIDS Clinical Trial Group Criteria. Division of AIDS. Table for grading severity of adult adverse experiences. August, 1992"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/1055049029008810"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410802"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051390"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199402000-00027"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4899-1268-8_27","volume-title":"Human Body Composition","author":"Azcue M","year":"1993","unstructured":"Azcue M, Neuman M G, Pencharz P. What does bioelectrical impedance spectroscopy (BIS) measure. Human Body Composition, K Ellis, G Eastman. Plenum Press, New York 1993; 121\u2013125"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(95)00049-4"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(94)90166-X"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25882"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024603517136"},{"key":"e_1_3_2_16_1","unstructured":"Ball A. Drugs use in HIV AIDS. Summary papers given in Track D of the XIIth International AIDS Conference Durban South Africa July 9\u201314. 2000 9\u201314"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2001.1151"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79417-4"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2741\/barve"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687639997278"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17558"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01169-Y"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1995.tb03507.x"},{"key":"e_1_3_2_25_1","first-page":"1200","volume":"279","author":"Bates D W","year":"1998","unstructured":"Bates D W. Drugs and adverse drug reactions: how worried should we be? JAMA 1998; 279: 1200\u20131205","journal-title":"Drugs and adverse drug reactions: how worried should we be? JAMA"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.274.1.29"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1992.tb139846.x"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00745-6"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199212000-00008"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80031-3"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00117-4"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J"},{"issue":"2","key":"e_1_3_2_33_1","first-page":"37","article-title":"Tranforming growth factor-b (TGF-b): A key role in liver fibrogenesis","volume":"22","author":"Bedossa P","year":"1995","unstructured":"Bedossa P, Paradis V. Tranforming growth factor-b (TGF-b): A key role in liver fibrogenesis. J. Hepatology 1995; 22(2 Suppl.)37\u201342","journal-title":"J. Hepatology"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.6.874"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300409"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.86.5.818"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70019-7"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199308000-00003"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601557"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32568-5"},{"issue":"1","key":"e_1_3_2_41_1","first-page":"97","article-title":"Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease","volume":"30","author":"Bode J C","year":"1995","unstructured":"Bode J C, Alscher D M, Wisser H, Bode C. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Alcohol Alcohol 1995; 30(1)97\u2013103","journal-title":"Alcohol Alcohol"},{"key":"e_1_3_2_42_1","first-page":"118","article-title":"Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behavior","volume":"72","author":"Bodsworth N J","year":"1996","unstructured":"Bodsworth N J, Cunningham P, Kaldor J. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behavior. Genitourin Med 1996; 72: 118\u2013122","journal-title":"Genitourin Med"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.22.3365"},{"key":"e_1_3_2_44_1","first-page":"407","article-title":"Commentaries on Landau's: The prospects of harm reduction approach among indigenous people in Canada: harm reduction\u2014already happening?","volume":"15","author":"Brady M","year":"1996","unstructured":"Brady M. Commentaries on Landau's: The prospects of harm reduction approach among indigenous people in Canada: harm reduction\u2014already happening?. Drugs Alcohol Rev 1996; 15: 407\u2013409","journal-title":"Drugs Alcohol Rev"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.20206"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80413-4"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92300-I"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90079-Q"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03400060056021"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)01351-3"},{"issue":"1","key":"e_1_3_2_52_1","first-page":"20","article-title":"Contradictory strategies: HIV and drugs","volume":"10","author":"Burrows D","year":"1996","unstructured":"Burrows D. Contradictory strategies: HIV and drugs. National AIDS Bulletin 1996; 10(1)20\u201321","journal-title":"National AIDS Bulletin"},{"key":"e_1_3_2_53_1","first-page":"2","article-title":"Drug use injects HIV AIDS into former Soviet Union","author":"Burrows D","year":"2002","unstructured":"Burrows D, Holmes D, Schwalbe N. Drug use injects HIV AIDS into former Soviet Union. AIDS Links 2002; 2","journal-title":"AIDS Links"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595239800187291"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1997.tb140041.x"},{"issue":"7","key":"e_1_3_2_56_1","first-page":"1016","article-title":"Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score","volume":"88","author":"Caldwell S H","year":"1993","unstructured":"Caldwell S H, Li X, Rourk R M, Millar A, Sosnowski K M, Sue M, Barritt A S, McCallum R W, Schiff E R. Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am. J. Gastroenterol 1993; 88(7)1016\u20131021","journal-title":"Am. J. Gastroenterol"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(99)00058-2"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.5.925"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.3.381"},{"key":"e_1_3_2_60_1","first-page":"\u200765","article-title":"Pathogenesis and management of HIV-associated drug hypersensitivity","author":"Carr A","year":"1995","unstructured":"Carr A, Cooper D A. Pathogenesis and management of HIV-associated drug hypersensitivity. AIDS Clin. Rev 1995; \u200765\u201397","journal-title":"AIDS Clin. Rev"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02854-3"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"issue":"4","key":"e_1_3_2_64_1","first-page":"421","volume":"19","author":"Carruthers S","year":"1995","unstructured":"Carruthers S, Loxley W. Hepatitis C and young drug users: are they about to join the epidemic? Australian J Public Health 1995; 19(4)421\u2013424","journal-title":"Hepatitis C and young drug users: are they about to join the epidemic? Australian J Public Health"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595239800187391"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1089\/08892220150217175"},{"key":"e_1_3_2_67_1","first-page":"313","article-title":"Recommendations for protection against viral hepatitis","volume":"34","author":"Centers for Disease Control and Prevention","year":"1985","unstructured":"Centers for Disease Control and Prevention. Recommendations for protection against viral hepatitis. MMWR 1985; 34: 313\u2013335","journal-title":"MMWR"},{"key":"e_1_3_2_68_1","first-page":"1","volume-title":"MMWR Recomm. Rep","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm. Rep. 1998; 47(RR-19: 1\u201339"},{"key":"e_1_3_2_69_1","volume-title":"Centers for Disease Control and Prevention","year":"2002","unstructured":"Centers for Disease Control and Prevention. HIV AIDS update a glance of HIV epidemics. 2002a, Available atwww.cdc.gov\/hiv\/pubs\/facts.htm accessed November 29"},{"issue":"7","key":"e_1_3_2_70_1","first-page":"1","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents","volume":"51","author":"Center for Disease Control and Prevention","year":"2002","unstructured":"Center for Disease Control and Prevention. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV, MMWR, 2002b; 51(RR-7)1\u201355","journal-title":"Recommendations of the Panel on Clinical Practices for Treatment of HIV, MMWR,"},{"key":"e_1_3_2_71_1","unstructured":"Centers for Disease Control and Prevention. National Center for Infectious Diseases. Viral hepatitis C fact sheet. Available at. 2002 www.cdc.gov\/ncdod\/diseases\/hepatitis\/c.fact.htm accessed on November 29"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80020-8"},{"key":"e_1_3_2_73_1","first-page":"210","article-title":"Prognostic factors in alcoholic liver disease","volume":"82","author":"Chedid A","year":"1991","unstructured":"Chedid A, Mendenhall C L, Garside P. Prognostic factors in alcoholic liver disease. Am. J. Gastroenterol 1991; 82: 210\u2013216","journal-title":"Am. J. Gastroenterol"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840130303"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(83)80240-6"},{"key":"e_1_3_2_76_1","unstructured":"Choi M. Y. Lee S. S Mac W. Y. Chan W. M. Low rates of needle-sharing in drug user attending the methadone clinics. Vancouver. Proceedings of the XI International Conference on AIDS. 1996"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_3_2_78_1","first-page":"311","volume-title":"The Global Burden of Disease The Global Burden of Disease","author":"Christopher J. L. Murray","year":"1996","unstructured":"The Global Burden of Disease The Global Burden of Disease, J. L. Murray Christopher, D. Lopez Alan. World Public Health, and The World Bank, Geneva 1996; volume 1: 311"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2001.06.964"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462001914913"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1995.tb01597.x"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290447"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115040-00003"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5245(00)27765-1"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310328"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342602"},{"issue":"9","key":"e_1_3_2_87_1","first-page":"1927","article-title":"Alcohol abuse, alcoholism, and damage to the immune system\u2013-a review","volume":"22","author":"Cook R T","year":"1998","unstructured":"Cook R T. Alcohol abuse, alcoholism, and damage to the immune system\u2013-a review. Alcohol Clin. Exp. Res 1998; 22(9)1927\u20131942","journal-title":"Alcohol Clin. Exp. Res"},{"key":"e_1_3_2_88_1","volume-title":"Drug use and HIV vulnerability. In: Manual for Drug Reducing Harm Asia, the Centre for Harm Reduction. Macfarlane Burnet Centre for Medical Research and Asian Harm Reduction Network","author":"Costigan G.","year":"2003","unstructured":"Costigan G., Crofts N., Reid G. eds. Drug use and HIV vulnerability. In: Manual for Drug Reducing Harm Asia, the Centre for Harm Reduction. Macfarlane Burnet Centre for Medical Research and Asian Harm Reduction Network. Chaingmai, Thailand 2003"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199510000-00003"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.31748"},{"key":"e_1_3_2_91_1","unstructured":"Dallabetta G Gavrilin S. Assessment of the HIV situation in selected sites in Kyrgzstan Uzbekistan and Kazakhstan. Report prepared for the USAID Regional Mission for Central Asia. 2001"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05413-5"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01679.x"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540260059037"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70072-7"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.17.1497"},{"key":"e_1_3_2_97_1","volume-title":"Textbook of AIDS. Baltimore","author":"Dieterich D T","year":"1993","unstructured":"Dieterich D T. Gastrointestinal manifestations of HIV disease. Textbook of AIDS. Baltimore, S Broder, T C Merigan, D Bolognesi. Williams & Wilkins. 1993"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116023"},{"key":"e_1_3_2_99_1","volume-title":"Hepatitis C Prevention Education for Injecting Drug Users in Australia","author":"Dowsett G.W.","year":"1999","unstructured":"Dowsett G.W., Turney L., Woolcock G., Thomson N. Hepatitis C Prevention Education for Injecting Drug Users in Australia. A Research Report. Commonwealth Department of Health and Aged Care, SydneyAustralia 1999"},{"key":"e_1_3_2_100_1","first-page":"55","article-title":"Human pharmacokinetics of ethanol","volume":"5","author":"Dubowski K M","year":"1976","unstructured":"Dubowski K M. Human pharmacokinetics of ethanol. I. Peak blood concentrations and elimination in male and female subjects. Alcohol Technical Reports 1976; 5: 55\u201363","journal-title":"I. Peak blood concentrations and elimination in male and female subjects. Alcohol Technical Reports"},{"key":"e_1_3_2_101_1","first-page":"5","article-title":"What is moderate drinking? Defining \u201cdrinks\u201d and drinking levels","volume":"23","author":"Dufour M C","year":"1999","unstructured":"Dufour M C. What is moderate drinking? Defining \u201cdrinks\u201d and drinking levels. Alcohol Res. Health 1999; 23: 5\u201314","journal-title":"Alcohol Res. Health"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.1.8"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92229-6"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.21.040181.003043"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90485-6"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-6-443"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020526"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50247"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-764"},{"key":"e_1_3_2_111_1","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus","volume":"6","author":"Eyster M E","year":"1993","unstructured":"Eyster M E, Diamondstone L S, Lien J M, Ehmann C, Quan S. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes 1993; 6: 602\u2013610","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"e_1_3_2_112_1","first-page":"1020","article-title":"Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease","volume":"84","author":"Eyster M E","year":"1994","unstructured":"Eyster M E, Fried M W, Di Bisceglie A M, Goedert J J. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84: 1020\u20131023","journal-title":"Multicenter Hemophilia Cohort Study. Blood"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11403-6"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01977.x"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.5.931"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.420"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9024300"},{"key":"e_1_3_2_118_1","article-title":"Panel on clinical practices for treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents","author":"Fauci A S","year":"2000","unstructured":"Fauci A S, Bartlett J G, Goosby E P, Smith M D. Panel on clinical practices for treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Federal Register 2000","journal-title":"Federal Register"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420170117"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890460412"},{"key":"e_1_3_2_121_1","first-page":"v","volume-title":"The Sixth World Food Survey","author":"Food and Agriculture Organization of the United Nations (FAO)","year":"1996","unstructured":"Food and Agriculture Organization of the United Nations (FAO). The Sixth World Food Survey. Rome, FAO 1996; v\u2013vi"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70234-8"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80411-5"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270132"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-22-9-921"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007346"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360730"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304223281620"},{"issue":"3","key":"e_1_3_2_130_1","first-page":"33","article-title":"and the Nara Liver Study Group. (1999). Prognostic factors in severe alcoholic liver injury","volume":"24","author":"Fujimoto M","unstructured":"Fujimoto M, Uemura M, Kojima H, Ishii Y, Ann T, Sakurai S, Okuda K, Noguchi K, Adachi S, Kitano H, Hoppo K, Higashino T, Takaya A, Fukui H. and the Nara Liver Study Group. (1999). Prognostic factors in severe alcoholic liver injury. Alcoholism Clin. Exp. Res, 24(3 suppl.)33\u201338","journal-title":"Alcoholism Clin. Exp. Res"},{"issue":"1","key":"e_1_3_2_131_1","first-page":"1190","article-title":"Brass C. Diabetus mellitus of a new onset during pegylated interferon and ribavirin therapy for chronic hepatitis C: observation from the WIN-R trial","volume":"38","author":"Furqaan A","unstructured":"Furqaan A, Jacobson I M, Hargrave T, Lawitz E, Migicovsky B, Reddy V, Terrault N, Brown Jr R S. Brass C. Diabetus mellitus of a new onset during pegylated interferon and ribavirin therapy for chronic hepatitis C: observation from the WIN-R trial. Hepatology, 38(Suppl. 1)1190","journal-title":"Hepatology"},{"key":"e_1_3_2_132_1","first-page":"D69","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"1","author":"Gabele E","year":"2003","unstructured":"Gabele E, Brenner D A, Rippe R A. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 1: D69\u201377","journal-title":"Front Biosci"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.17711"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i6.1261"},{"key":"e_1_3_2_135_1","first-page":"1130","article-title":"Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C","volume":"92","author":"Garcia-Samaniego J","year":"1997","unstructured":"Garcia-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The American Journal of Gastroenterology 1997; 92: 1130","journal-title":"The American Journal of Gastroenterology"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199802001-00004"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.86.5.655"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(98)00060-8"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952997909001725"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.110973"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16661"},{"issue":"1","key":"e_1_3_2_142_1","first-page":"385","article-title":"Pharmacodynamics and pharmacikinetics of hepatitis C virus (HCV and pegylated interferon alpha 2 b in human immunodeficiency virus (HIV) co-infected patients","volume":"38","author":"Golia P","year":"2003","unstructured":"Golia P. Pharmacodynamics and pharmacikinetics of hepatitis C virus (HCV and pegylated interferon alpha 2 b in human immunodeficiency virus (HIV) co-infected patients. Hepatology 2003; 38(Suppl. 1)385","journal-title":"Hepatology"},{"key":"e_1_3_2_143_1","first-page":"1849","article-title":"Lack of evidence for the heterosexual transmission","volume":"87","author":"Gordon S C","year":"1992","unstructured":"Gordon S C, Patel A H, Kulesza G W. Lack of evidence for the heterosexual transmission. Am. J. Gastroenterol 1992; 87: 1849\u20131851","journal-title":"Am. J. Gastroenterol"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00109-5"},{"issue":"5","key":"e_1_3_2_145_1","first-page":"429","article-title":"Interactions between methadone and medications used to treat HIV infection: a review","volume":"67","author":"Gourevitch M N","year":"2000","unstructured":"Gourevitch M N, Freidland G H. Interactions between methadone and medications used to treat HIV infection: a review. The Mount Sinai J. Med 2000; 67(5 and 6)429\u2013436","journal-title":"The Mount Sinai J. Med"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1086\/321909"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93811372.x"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.2.355"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1977.38.1274"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118509"},{"key":"e_1_3_2_151_1","volume-title":"Panel on Clinical Practices for Treatment of HIV Infection. Available at","author":"Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents","year":"2001","unstructured":"Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. Panel on Clinical Practices for Treatment of HIV Infection. Available at. 2001, http:\/\/www.aidsinfo.nih.gov accessed February 5"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371102"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<253::AID-JMV13>3.0.CO;2-F"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199712)53:4<354::AID-JMV7>3.0.CO;2-6"},{"key":"e_1_3_2_156_1","first-page":"463","article-title":"The impact of co-infection with hepatatis C virus and HIV on the tolerability of antiretroviral therapy","volume":"14","author":"Hauser P M","year":"2000","unstructured":"Hauser P M, Blanc D S, Bille J, Nahimana A, Francioli P. The impact of co-infection with hepatatis C virus and HIV on the tolerability of antiretroviral therapy. J. of Acquir Immune Defic. Syndr 2000; 14: 463\u2013464","journal-title":"J. of Acquir Immune Defic. Syndr"},{"key":"e_1_3_2_157_1","volume-title":"HIV and AIDS in Canada: Surveillance Report to December 31, 1999. Division of HIV AIDS Surveillance, Bureau of HIV AIDS, STD and TB, Laboratory Centre for Disease Control","author":"Health Canada","year":"2000","unstructured":"Health Canada. HIV and AIDS in Canada: Surveillance Report to December 31, 1999. Division of HIV AIDS Surveillance, Bureau of HIV AIDS, STD and TB, Laboratory Centre for Disease Control. Minister of Public Works and Government Services Canada. 2000"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432302"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199811000-00006"},{"key":"e_1_3_2_160_1","volume-title":"Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, California, January 30\u2013February 2, 2000. Abstract 60, 2000","author":"Hetherington S","unstructured":"Hetherington S, Steel H, Naderer O, Cutrell A, Powell W, Sykes R. Hypersensitivity reactions during therapy with abacavir: analysis of 636 cases for clinical presentation and risk factors. Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, California, January 30\u2013February 2, 2000. Abstract 60, 2000"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1086\/315396"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11722-3"},{"issue":"5","key":"e_1_3_2_163_1","first-page":"659","article-title":"Improved survival among HIV-infected patients after the initiation of triple-drug antiretroviral regimens","volume":"160","author":"Hogg R S","year":"1999","unstructured":"Hogg R S, Yip B, Kully C, Craib K, O'Shaughnessy M V, Schechter M T, Montaner J S. G. Improved survival among HIV-infected patients after the initiation of triple-drug antiretroviral regimens. CMAJ 1999; 160(5)659\u2013665","journal-title":"CMAJ"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1231"},{"key":"e_1_3_2_165_1","first-page":"416","article-title":"High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advances HIV infection","volume":"4","author":"Homman C","year":"1991","unstructured":"Homman C, Krogsgaard K, Pederson C, Anderson P, Nielsen J O. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advances HIV infection. J Aquir Immune Defic Syndr 1991; 4: 416\u2013420","journal-title":"J Aquir Immune Defic Syndr"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90092-Q"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1159\/000007532"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90489-3"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150404"},{"key":"e_1_3_2_170_1","volume-title":"1997 CFR & ICH Guidelines1st","author":"ICH-GCP International Conference on Harmonisation Expert Working Group","year":"1997","unstructured":"ICH-GCP International Conference on Harmonisation Expert Working Group. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice. 1997 CFR & ICH Guidelines1st. Barnett International PAREXEL, , PA 1997; 1"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180109"},{"issue":"3","key":"e_1_3_2_172_1","first-page":"257","article-title":"Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors","volume":"26","author":"Iribarne C","year":"1998","unstructured":"Iribarne C, Berthou F, Carlhant D, Dreano Y, Picart D, Lohezic F, Riche C. Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors. Drug Metabolism and Disposition 1998; 26(3)257\u2013260","journal-title":"Drug Metabolism and Disposition"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1991.tb00518.x"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33539"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00210-7"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24236"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb04004.x"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90106-4"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430180043006"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431802"},{"key":"e_1_3_2_181_1","unstructured":"Joint United Nations Programme on HIV AIDS World Health Organization. AIDS Epidemic Update. 2000"},{"key":"e_1_3_2_182_1","volume-title":"Extrapolating long-term HIV AIDS survival in the post HAART era. Abs. 1158. Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Justice A.","year":"1999","unstructured":"Justice A., Chang C. H., Fusco J. et al. Extrapolating long-term HIV AIDS survival in the post HAART era. Abs. 1158. Interscience Conference on Antimicrobial Agents and Chemotherapy. 1999"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03260250028021"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100333"},{"key":"e_1_3_2_185_1","first-page":"2378","article-title":"Liver damage attributed to the use of disulfiram","volume":"18","author":"Kerkhof S C","year":"1995","unstructured":"Kerkhof S C, de Dooelder P. F., Harinck H I, Stricker B H. Liver damage attributed to the use of disulfiram. Ned Tijdschr Geneeskd 1995; 18: 2378","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"5","key":"e_1_3_2_186_1","first-page":"360","article-title":"Viral dynamics in hepatitis C","volume":"3","author":"Kershenobich D","year":"2001","unstructured":"Kershenobich D, Henonin C H. Viral dynamics in hepatitis C. Isr Med Assoc J 2001; 3(5)360\u2013363","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"e_1_3_2_187_1","first-page":"744A","article-title":"Combination therapy for HCV affects the [abs. 1217] HIV viral load in patients receiving highly active entiretroviral therapy (HAART)","volume":"38","author":"Kertznus J","year":"2003","unstructured":"Kertznus J, Molina E G, Regev A, Schiff E R. Combination therapy for HCV affects the [abs. 1217] HIV viral load in patients receiving highly active entiretroviral therapy (HAART). Abs. 1217, Hepatology 2003; 38(Suppl. 1)744A","journal-title":"Abs. 1217, Hepatology"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.106.2763.589"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120409"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00454-6"},{"key":"e_1_3_2_191_1","first-page":"436","article-title":"Komplikationer ved Antabusbehandking","volume":"69","author":"Knutsen G","year":"1949","unstructured":"Knutsen G. Komplikationer ved Antabusbehandking. Tidsskr Nor Laegeforen 1949; 69: 436","journal-title":"Tidsskr Nor Laegeforen"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199503000-00001"},{"key":"e_1_3_2_193_1","first-page":"229","volume-title":"Pathophysiology and treatment of the AIDS wasting syndrome. In: Volberding, P., Jacobson, M. A., eds. AIDS Clinical Review 1995 1996","author":"Kotler D P","year":"1996","unstructured":"Kotler D P, Grunfeld C. Pathophysiology and treatment of the AIDS wasting syndrome. In: Volberding, P., Jacobson, M. A., eds. AIDS Clinical Review 1995 1996. Marcel Dekker, New York 1996; 229\u2013275"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/50.3.444"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/42.6.1255"},{"key":"e_1_3_2_196_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02643.x"},{"key":"e_1_3_2_197_1","unstructured":"Kramer J. R. Giordano T. Souchek J. El-Serag H. The effect of hepatitis C coinfection on the risk of fulminant hepatic failure in patients with HIV in the HAART and pre-HAART eras m1213. 2004 abs. 10856 Digestive Disease Week"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-4-598"},{"key":"e_1_3_2_199_1","doi-asserted-by":"publisher","DOI":"10.1089\/08892220260139495"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb03314.x"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.116145"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03618-7"},{"key":"e_1_3_2_203_1","first-page":"1","article-title":"Acyclovir","volume":"18","author":"Laskin U","year":"1984","unstructured":"Laskin U. Acyclovir. Rational Drug Ther 1984; 18: 1","journal-title":"Rational Drug Ther"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1330418"},{"key":"e_1_3_2_205_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450107"},{"issue":"6","key":"e_1_3_2_206_1","first-page":"1252","article-title":"Stability of methadone in four vehicles for oral administration","volume":"48","author":"Lauriault G","year":"1991","unstructured":"Lauriault G, LeBelle M J, Lodge B A. Stability of methadone in four vehicles for oral administration. Am J Hosp Pharm 1991; 48(6)1252\u20131256","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/630301"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"e_1_3_2_209_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712113372406"},{"key":"e_1_3_2_210_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196209000-00003"},{"key":"e_1_3_2_211_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1975.tb19146.x"},{"key":"e_1_3_2_212_1","first-page":"1217","article-title":"Absence of drug induced hepatotoxicity in heroin and metamphetamine users","volume":"56","author":"Levin R A","year":"1969","unstructured":"Levin R A. Absence of drug induced hepatotoxicity in heroin and metamphetamine users. Gastroenterology 1969; 56: 1217","journal-title":"Gastroenterology"},{"key":"e_1_3_2_213_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.8559"},{"key":"e_1_3_2_214_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408360091174312"},{"key":"e_1_3_2_215_1","first-page":"75","volume-title":"International Handbook of Alcohol Dependence and Problems","author":"Lieber C S","year":"2001","unstructured":"Lieber C S. Molecular basis and metabolic consequences of ethanol metabolism. International Handbook of Alcohol Dependence and Problems, N Heather, T J Peters, T. Stockwell. John Wiley & Sons, New York 2001; 75\u2013102"},{"key":"e_1_3_2_216_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.2.437"},{"issue":"11","key":"e_1_3_2_217_1","first-page":"1","article-title":"for the Veterans Affair Cooperative Study Group 391 I. Veteran Affairs Cooperative study of polyenylphosphosphatidylcholine in alcoholic liver disease: effects on drinking behaviour by nurse physician teams","volume":"27","author":"Lieber C S","year":"2003","unstructured":"Lieber C S, Weiss D, Grozmann R, Paronetto F, Schenker S. for the Veterans Affair Cooperative Study Group 391 I. Veteran Affairs Cooperative study of polyenylphosphosphatidylcholine in alcoholic liver disease: effects on drinking behaviour by nurse physician teams. Alcohol Clin Exp Res 2003a; 27(11)1\u201310","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"e_1_3_2_218_1","first-page":"11","article-title":"(2003b). for the Veterans Affair Cooperative Study Group 391 II. Veteran Affairs Cooperative study of polyenylphosphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber C S","unstructured":"Lieber C S, Weiss D, Grozmann R, Paronetto F, Schenker S. (2003b). for the Veterans Affair Cooperative Study Group 391 II. Veteran Affairs Cooperative study of polyenylphosphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res, 27(11)11\u201318","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_3_2_219_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.6.1360"},{"key":"e_1_3_2_220_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02235538"},{"key":"e_1_3_2_221_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.3.296"},{"key":"e_1_3_2_222_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24839"},{"key":"e_1_3_2_223_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200204000-00003"},{"key":"e_1_3_2_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00361-1"},{"key":"e_1_3_2_225_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507133330202"},{"key":"e_1_3_2_226_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200103090-00006"},{"key":"e_1_3_2_227_1","first-page":"67","article-title":"Safety of combination interferon alfa-2b ribavirin therapy in chronic hepatitis C-relapsed and treatment naive patients","volume":"19","author":"Maddrey W","year":"1999","unstructured":"Maddrey W. Safety of combination interferon alfa-2b ribavirin therapy in chronic hepatitis C-relapsed and treatment naive patients. Semin. Liver Dis 1999; 19: 67\u201375","journal-title":"Semin. Liver Dis"},{"key":"e_1_3_2_228_1","first-page":"493","article-title":"Double blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers","volume":"12","author":"Magnusson C R","year":"1977","unstructured":"Magnusson C R, Douglas R G, Jr, Betts R F. Double blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers. Antimicrob Agents Chemother 1977; 12: 493","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_2_229_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.351"},{"key":"e_1_3_2_230_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007260"},{"key":"e_1_3_2_231_1","first-page":"98","article-title":"EASL international consensus conference on hepatitis C","volume":"32","author":"Marcellin P","year":"2000","unstructured":"Marcellin P. EASL international consensus conference on hepatitis C. J Hepatol 2000; 32: 98\u2013112","journal-title":"J Hepatol"},{"key":"e_1_3_2_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90405-8"},{"key":"e_1_3_2_233_1","doi-asserted-by":"publisher","DOI":"10.1086\/367643"},{"key":"e_1_3_2_234_1","volume-title":"Methods and Results","author":"Mathers C D","year":"2002","unstructured":"Mathers C D, Stein C, Ma Fat D. Global Burden of Disease 2000: Version 2. Methods and Results. World Health Organization, Geneva 2002"},{"issue":"3","key":"e_1_3_2_235_1","first-page":"S197","article-title":"HIV-associated lipodystrophy syndrome","volume":"14","author":"Mauss S","year":"2000","unstructured":"Mauss S. HIV-associated lipodystrophy syndrome. AIDS 2000; 14(Suppl. 3)S197\u2013S207","journal-title":"AIDS"},{"issue":"1","key":"e_1_3_2_236_1","first-page":"1215","article-title":"A prospective controlled study assessing the treatment of chronic hepatitis C in patients with methadone maintenance","volume":"38","author":"Mauss S","year":"2003","unstructured":"Mauss S, Berger F, Schmutz G, Jacob B, Goelz J. A prospective controlled study assessing the treatment of chronic hepatitis C in patients with methadone maintenance. Hepatology 2003; 38(Suppl. 1)1215","journal-title":"Hepatology"},{"key":"e_1_3_2_237_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090302"},{"key":"e_1_3_2_238_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.967100710.x"},{"key":"e_1_3_2_239_1","first-page":"315","volume-title":"Hepatocellular carcinoma and viral hepatitis. In: Wilson, R.A., ed. Viral Hepatitis","author":"McMahon B J","year":"1997","unstructured":"McMahon B J. Hepatocellular carcinoma and viral hepatitis. In: Wilson, R.A., ed. Viral Hepatitis. Marcel Dekker, New York 1997; 315\u2013330"},{"key":"e_1_3_2_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90523-8"},{"key":"e_1_3_2_241_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199714000-00002"},{"issue":"10","key":"e_1_3_2_242_1","first-page":"2493","article-title":"Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification","volume":"76","author":"Mellor J","year":"1995","unstructured":"Mellor J, Holmes E C, Jarvis L M. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995; 76(Pt 10)2493\u20132507","journal-title":"The International HCV Collaborative Study Group. J Gen Virol"},{"key":"e_1_3_2_243_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.2.417-423.1996"},{"issue":"7","key":"e_1_3_2_244_1","first-page":"1022","article-title":"Epidemiology of hepatitis C among veterans with alcoholic liver disease","volume":"88","author":"Mendenhall C L","year":"1993","unstructured":"Mendenhall C L, Moritz T, Rouster S, Roselle G, Polito A, Quan S, DiNelle R K. Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275. Am J Gastroenterol 1993a; 88(7)1022\u20131026","journal-title":"The VA Cooperative Study Group 275. Am J Gastroenterol"},{"issue":"5","key":"e_1_3_2_245_1","first-page":"95","article-title":"Relevance of anti-HCV reactivity in patients with alcoholic hepatitis","volume":"28","author":"Mendenhall C L","year":"1993","unstructured":"Mendenhall C L, Moritz T, Chedid A, Polito A J, Quan S, Rouster S, Roselle G. Relevance of anti-HCV reactivity in patients with alcoholic hepatitis. VA cooperative Study Group #275. Gastroenterol Jpn 1993b; 28(Suppl 5)95\u2013100","journal-title":"VA cooperative Study Group #275. Gastroenterol Jpn"},{"key":"e_1_3_2_246_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140624"},{"key":"e_1_3_2_247_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200010200-00025"},{"key":"e_1_3_2_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(96)00044-5"},{"key":"e_1_3_2_249_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91196-7"},{"key":"e_1_3_2_250_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03201-2"},{"key":"e_1_3_2_251_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510406"},{"key":"e_1_3_2_252_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.7.1035"},{"key":"e_1_3_2_253_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.3.897"},{"key":"e_1_3_2_254_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02440.x"},{"key":"e_1_3_2_255_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6807.922-a"},{"key":"e_1_3_2_256_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00667.x"},{"key":"e_1_3_2_257_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910010-00017"},{"key":"e_1_3_2_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(86)90301-3"},{"key":"e_1_3_2_259_1","first-page":"956","article-title":"Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection","volume":"77","author":"Mulligan K","year":"1993","unstructured":"Mulligan K, Grunfeld C, Hellerstein M K, Neese R A, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 77: 956\u2013962","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_260_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02989215"},{"key":"e_1_3_2_261_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80006-1"},{"key":"e_1_3_2_262_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90912-U"},{"issue":"2","key":"e_1_3_2_263_1","first-page":"221","article-title":"Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption","author":"Naranjo C A","year":"1993","unstructured":"Naranjo C A, Bremner K E. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption. Alcohol Alcohol (Suppl. 2) 1993, Suppl. 2: 221\u2013229","journal-title":"Alcohol Alcohol (Suppl. 2)"},{"key":"e_1_3_2_264_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80065-0"},{"key":"e_1_3_2_265_1","first-page":"1","article-title":"Cytokines and inflamed liver","volume":"23","author":"Neuman M G","year":"1998","unstructured":"Neuman M G. Cytokines and inflamed liver. Clin Invest Med 1998; 23: 1\u20136","journal-title":"Clin Invest Med"},{"key":"e_1_3_2_266_1","first-page":"601","article-title":"Cytokines and inflamed liver","volume":"33","author":"Neuman M G","year":"1999","unstructured":"Neuman M G. Cytokines and inflamed liver. Clin Biochem 1999; 33: 601\u2013605","journal-title":"Clin Biochem"},{"key":"e_1_3_2_267_1","doi-asserted-by":"publisher","DOI":"10.1080\/20014091084182"},{"key":"e_1_3_2_268_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00209-0"},{"issue":"4","key":"e_1_3_2_269_1","first-page":"313","article-title":"Cytokines in alcoholic liver","volume":"27","author":"Neuman M G","year":"2004","unstructured":"Neuman M G. Cytokines in alcoholic liver. Alcohol Research & Health 2004; 27(4)313\u2013322","journal-title":"Alcohol Research & Health"},{"key":"e_1_3_2_270_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(02)00214-8"},{"key":"e_1_3_2_271_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(99)00053-3"},{"key":"e_1_3_2_272_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00343.x"},{"key":"e_1_3_2_273_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02404.x"},{"key":"e_1_3_2_274_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08275-2"},{"key":"e_1_3_2_275_1","first-page":"344","volume-title":"Drug-induced apoptosis of skin cells and liver. In: Cameron, R.G., Feuer, G., eds. Handbook of Experimental Pharmacology: Apoptosis Modulation by Drugs","author":"Neuman M G","year":"1999","unstructured":"Neuman M G, Cameron R G, Shear N H, Feuer G G, Feuer G. Drug-induced apoptosis of skin cells and liver. In: Cameron, R.G., Feuer, G., eds. Handbook of Experimental Pharmacology: Apoptosis Modulation by Drugs. Springer Verlag, Heidelberg 1999b; 142: 344\u2013355"},{"key":"e_1_3_2_276_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(02)00198-2"},{"issue":"3","key":"e_1_3_2_277_1","first-page":"102","article-title":"Alcoholic liver injury and apoptosis: synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism","volume":"27","author":"Neuman M G","year":"2002","unstructured":"Neuman M G, Katz G G, Malkiewicz I, Mathurin P, Tsukamoto H, Adachi M, Ishii H, Colell A, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa J C, Casey C A. Alcoholic liver injury and apoptosis: synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism. Alcohol, 2002d; 27(3)102\u2013112","journal-title":"Alcohol,"},{"key":"e_1_3_2_278_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200212000-00008"},{"key":"e_1_3_2_279_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00146-6"},{"key":"e_1_3_2_280_1","doi-asserted-by":"crossref","first-page":"94A","DOI":"10.1111\/j.1530-0277.1996.tb01739.x","article-title":"Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma\u2014its relationship to alcohol drinking and the age of transfusion","volume":"20","author":"Noda K","year":"1996","unstructured":"Noda K, Yoshihara H, Suzuki Y, Yamada Y, Kasahari A, Hayashi N, Fusamoto H. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma\u2014its relationship to alcohol drinking and the age of transfusion. Alcohol Clin Exp Res 1996; 20(Suppl.)94A\u2013100A","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_3_2_281_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199802000-00006"},{"issue":"4","key":"e_1_3_2_282_1","first-page":"283","article-title":"Seroprevalence of hepatitis C virus in outpatients of health care services in Burundi","volume":"75","author":"Ntakarutimana V","year":"1995","unstructured":"Ntakarutimana V, Delaporte E, Pollet D, Demedts P, Scharpe S. Seroprevalence of hepatitis C virus in outpatients of health care services in Burundi. Ann Soc Belg Med Trop 1995; 75(4)283\u2013290","journal-title":"Ann Soc Belg Med Trop"},{"issue":"7","key":"e_1_3_2_283_1","first-page":"1374","article-title":"Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers","volume":"91","author":"Ohnishi K","year":"1996","unstructured":"Ohnishi K, Matsuo S, Matsutani K, Itahashi M, Kakihara K, Suzuki K, Ito S, Fujiwara K. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996; 91(7)1374\u20131379","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_2_284_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094883"},{"key":"e_1_3_2_285_1","first-page":"197","volume-title":"Human Body Composition","author":"Oliver C. J.","year":"2003","unstructured":"Oliver C. J., Rose A., Blagojevic N., Dwyer R., Gold D., Allen H. J. Total body protein status of males infected with the human immunodeficiency virus. In:. Human Body Composition, K. Ellis, G. Eastman. Plenum Press, New York 2003; 197\u2013201"},{"key":"e_1_3_2_286_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528050-00004"},{"key":"e_1_3_2_287_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200503"},{"key":"e_1_3_2_288_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199505010-00003"},{"key":"e_1_3_2_289_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200007000-00001"},{"key":"e_1_3_2_290_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_3_2_291_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199511000-00009"},{"key":"e_1_3_2_292_1","unstructured":"Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. 1998 http:\/\/www.aidsinfo.nih.gov\/guidelines"},{"key":"e_1_3_2_293_1","first-page":"1225","article-title":"Hepatitis C antibodies in chronic alcoholic patients","volume":"12","author":"Pares A","year":"1990","unstructured":"Pares A, Barera J, Caballeria J. Hepatitis C antibodies in chronic alcoholic patients. Association with severity of liver injury. Hepatology 1990; 12: 1225","journal-title":"Association with severity of liver injury. Hepatology"},{"key":"e_1_3_2_294_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/32.6.1246"},{"key":"e_1_3_2_295_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.6.1139"},{"key":"e_1_3_2_296_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001280-00023"},{"key":"e_1_3_2_297_1","first-page":"8","volume-title":"Final results of ANRS HC02-RIBAVIC: a randomized controlled trial of pegylated-interferon-alfa-2b plus ribavirin vs interferon alfa- 2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-Infected patients. Abstract 117LB. 11th Conference on Retroviruses and Opportunistic Infections","author":"Perronne C.","year":"2004","unstructured":"Perronne C., Carrat F., Bani-Sadr F., Pol S., Rosenthal E., Lunel F., Morand P. et al. Final results of ANRS HC02-RIBAVIC: a randomized controlled trial of pegylated-interferon-alfa-2b plus ribavirin vs interferon alfa- 2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-Infected patients. Abstract 117LB. 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA February, 2004; 8\u201311"},{"key":"e_1_3_2_298_1","first-page":"82","volume-title":"Esquire","author":"Pesman C","year":"2003","unstructured":"Pesman C. Side effects may include death. Esquire. 2003; November: 82\u201391"},{"key":"e_1_3_2_299_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500040603"},{"key":"e_1_3_2_300_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250535"},{"key":"e_1_3_2_301_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00163-0"},{"key":"e_1_3_2_302_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490050148099"},{"issue":"9","key":"e_1_3_2_303_1","first-page":"4671S","article-title":"Isoprinosine and imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms","volume":"45","author":"Pompidou A","year":"1985","unstructured":"Pompidou A, Delsaux M C, Telvi L. Isoprinosine and imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms. Cancer Res 1985; 45(9 Suppl.)4671S\u20134673S","journal-title":"Cancer Res"},{"key":"e_1_3_2_304_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05712-8"},{"key":"e_1_3_2_305_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07642-8"},{"key":"e_1_3_2_306_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.1999.0071"},{"key":"e_1_3_2_307_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19347"},{"issue":"7","key":"e_1_3_2_308_1","first-page":"e286","article-title":"Bautista AP Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics","volume":"1","author":"Prakash O","year":"2002","unstructured":"Prakash O, Mason A, Luftig R B. Bautista AP Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics. Front Biosci 2002; 1(7)e286\u2013e300","journal-title":"Front Biosci"},{"key":"e_1_3_2_309_1","volume-title":"Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Perinatal HIV Guidelines Working Group","year":"2001","unstructured":"Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Perinatal HIV Guidelines Working Group. January 24, 2001, Available at:http:\/\/www.aidsinfo.nih.gov accessed February 14,2001"},{"key":"e_1_3_2_310_1","unstructured":"Puffer R Griffith G W. Patterns of Urban Mortality. Pan American Health Organization Scientific Publication No. 151 Washington DC 1967"},{"key":"e_1_3_2_311_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.1.13.34667"},{"issue":"4","key":"e_1_3_2_312_1","first-page":"496","article-title":"for the Canadian HIV Trials Network Working Group. Guidelines for antiretroviral therapy for HIV infection","volume":"158","author":"Rachlis A R","year":"1998","unstructured":"Rachlis A R, Zarowny D P. for the Canadian HIV Trials Network Working Group. Guidelines for antiretroviral therapy for HIV infection. Can Med Assoc J 1998; 158(4)496\u2013505","journal-title":"Can Med Assoc J"},{"key":"e_1_3_2_313_1","unstructured":"Ravitch J R Sadler B M McDowell J A Walsh J S.. In vivo and in vitro studies of the potential for drug interactions involving the antiretroviral 1592 in humans. 5th Conference of Retroviruses and Opportunistic Infections. 1998"},{"key":"e_1_3_2_314_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300319"},{"key":"e_1_3_2_315_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21747"},{"key":"e_1_3_2_316_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00467.x"},{"key":"e_1_3_2_317_1","volume-title":"Comparative Quantification of Health Risks: Global and Regional Burden of Disease Due to Selected Major Risk Factors","author":"Rehm J","unstructured":"Rehm J, Room R, Monteiro M, Gmel G, Graham K. (in press) Alcohol. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Due to Selected Major Risk Factors, M Ezzati, A D Lopez, A Rodgers, C JL Murray. WHO, Geneva"},{"key":"e_1_3_2_318_1","doi-asserted-by":"publisher","DOI":"10.1159\/000072222"},{"key":"e_1_3_2_319_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30766-0"},{"key":"e_1_3_2_320_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040523"},{"key":"e_1_3_2_321_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93913859.x"},{"key":"e_1_3_2_322_1","doi-asserted-by":"publisher","DOI":"10.1086\/345770"},{"issue":"1","key":"e_1_3_2_323_1","first-page":"30","article-title":"Hepatitis C and HIV co-infection. Current aspects of therapy","volume":"9","author":"Rockstroh J K","year":"2002","unstructured":"Rockstroh J K. Hepatitis C and HIV co-infection. Current aspects of therapy. MMW Fortschr Med 2002; 9(Suppl. 1)30\u201332","journal-title":"MMW Fortschr Med"},{"key":"e_1_3_2_324_1","first-page":"829","article-title":"Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV co-infected heamophiliacs","volume":"12","author":"Rockstroh J K","year":"1998","unstructured":"Rockstroh J K, Thiesen A, Kaiser R, Sauerbruch T, Spengler J. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV co-infected heamophiliacs. AIDS 1998; 12: 829\u2013890","journal-title":"AIDS"},{"key":"e_1_3_2_325_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2000.00230.x"},{"key":"e_1_3_2_326_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80048-7"},{"key":"e_1_3_2_327_1","first-page":"18","article-title":"Non viral hepatitis in drug addicts","volume":"95","author":"Rosenblate H J","year":"1973","unstructured":"Rosenblate H J, Einstein R, Baldwin D, Homes A W. Non viral hepatitis in drug addicts. Arch Patol 1973; 95: 18\u201321","journal-title":"Arch Patol"},{"key":"e_1_3_2_328_1","first-page":"498","article-title":"Alcoholism is associated with hepatitis C but not hepatitis B in an urban population","volume":"91","author":"Rosman A S","year":"1996","unstructured":"Rosman A S, Waraich A, Galvin K. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol 1996; 91: 498\u2013505","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_2_329_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.217"},{"key":"e_1_3_2_330_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200301000-00017"},{"key":"e_1_3_2_331_1","doi-asserted-by":"publisher","DOI":"10.1086\/517808"},{"key":"e_1_3_2_332_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.164"},{"issue":"1","key":"e_1_3_2_333_1","first-page":"39","article-title":"TT virus infection in adult beta-thalassemia major patients","volume":"86","author":"Sampietro M","year":"2001","unstructured":"Sampietro M, Tavazzi D, Martinez di Montemuros F, Cerino M, Zatelli S, Lunghi G, Orlandi A, Fargion S, Fiorelli G, Cappellini M D. TT virus infection in adult beta-thalassemia major patients. Haematologica 2001; 86(1)39\u201343","journal-title":"Haematologica"},{"key":"e_1_3_2_334_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/28.Supplement_1B.85"},{"key":"e_1_3_2_335_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50031"},{"key":"e_1_3_2_336_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.4.562"},{"key":"e_1_3_2_337_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-11-199612010-00002"},{"key":"e_1_3_2_338_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260707"},{"key":"e_1_3_2_339_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31981-2"},{"key":"e_1_3_2_340_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272703"},{"key":"e_1_3_2_341_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360702"},{"key":"e_1_3_2_342_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.10.1433"},{"key":"e_1_3_2_343_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.414"},{"issue":"1","key":"e_1_3_2_344_1","first-page":"abs.70","article-title":"Predictors of antiretroviral-related hepatotoxicity in the adults AIDS clinical trials group (AACTG)","volume":"38","author":"Servoss J","year":"2003","unstructured":"Servoss J, Kitch D, Andersen J, Robbins G K, Reisler R B, Chung R T. Predictors of antiretroviral-related hepatotoxicity in the adults AIDS clinical trials group (AACTG). Hepatology 2003; 38(Suppl. 1)abs.70","journal-title":"Hepatology"},{"key":"e_1_3_2_345_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04530.x"},{"key":"e_1_3_2_346_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190538"},{"key":"e_1_3_2_347_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.3.385"},{"key":"e_1_3_2_348_1","volume-title":"The Cost of substance Abuse in Canada. Ottawa","author":"Single E.","year":"1996","unstructured":"Single E., Robson L., Xie X., Rehm J. The Cost of substance Abuse in Canada. Ottawa. Canadian Centre on Substance Abuse, Ontario 1996b"},{"key":"e_1_3_2_349_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02645.x"},{"key":"e_1_3_2_350_1","first-page":"400","article-title":"Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy","volume":"11","author":"Soriano V","year":"1997","unstructured":"Soriano V, Bravo R, Garcia-Samaniego J, Castilla J, Gonzalez J, Castro A, Llibre J M. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis HIV Spanish Study Group. AIDS 1997; 11: 400\u2013401","journal-title":"Hepatitis HIV Spanish Study Group. AIDS"},{"key":"e_1_3_2_351_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.585"},{"key":"e_1_3_2_352_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80001-3"},{"key":"e_1_3_2_353_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00311-7"},{"key":"e_1_3_2_354_1","unstructured":"Spinetti A Puito M Donato F. Increase of liver related in hospital mortality in a cohort of Italian seropositives after introduction of HAART: role of hepatitis virus coinfections. Abstract TuPe3184 Presented at the XIII International AIDS Conference Durban South AfricaSouth Africa July 2000. 2000"},{"key":"e_1_3_2_355_1","first-page":"133","volume-title":"Pharmacology Self-Assessment Program4th","author":"Sproule B A","year":"2002","unstructured":"Sproule B A. Substance abuse. Pharmacology Self-Assessment Program4th, B A Mueller, K E Bertch, T S Dunsworth, S C Fagan, M S Hayney, M B O\u2019Connell, G T Schumock, D F Thompson, J E Tisdale, D M Witt, B J. Zarowitz. American College of Clinical Pharmacy, Kansas City 2002; 133\u2013166"},{"key":"e_1_3_2_356_1","doi-asserted-by":"publisher","DOI":"10.1086\/520144"},{"key":"e_1_3_2_357_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912163412502"},{"key":"e_1_3_2_358_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00144-7"},{"key":"e_1_3_2_359_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.62.1.92"},{"key":"e_1_3_2_360_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199503010-00004"},{"key":"e_1_3_2_361_1","article-title":"AASLD Practice Guideline: Diagnosis, Management, and Treatment of Hepatitis C","author":"Strader D B","unstructured":"Strader D B, Wright T, Thomas D L, Seeff L B. AASLD Practice Guideline: Diagnosis, Management, and Treatment of Hepatitis C. American Association for the Study of Liver Diseases, available at www.interscience.wiley.com","journal-title":"American Association for the Study of Liver Diseases"},{"key":"e_1_3_2_362_1","doi-asserted-by":"publisher","DOI":"10.1086\/313842"},{"key":"e_1_3_2_363_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"e_1_3_2_364_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019711812074"},{"key":"e_1_3_2_365_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199708000-00034"},{"key":"e_1_3_2_366_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6997(24)01501-1"},{"key":"e_1_3_2_367_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00010-8"},{"key":"e_1_3_2_368_1","first-page":"534","article-title":"Selective inhivition of antigen-specific T lymphocytes proliferation by acute ethanol exposure","volume":"54","author":"Szabo G","year":"1993","unstructured":"Szabo G, Verma B, Catalano D. Selective inhivition of antigen-specific T lymphocytes proliferation by acute ethanol exposure. The role of impaired monocyte antigen-presentation capacity and mediator production. J Leuk Biol 1993; 54: 534\u2013544","journal-title":"The role of impaired monocyte antigen-presentation capacity and mediator production. J Leuk Biol"},{"issue":"1","key":"e_1_3_2_369_1","first-page":"7","article-title":"Relationship between alcoholic liver disease and HCV infection","author":"Takase S","year":"1993","unstructured":"Takase S, Takada N, Sawada M, Tsutsumi M, Takada A. Relationship between alcoholic liver disease and HCV infection. Alcohol Alcohol 1993, Suppl. 1A: 7\u201384","journal-title":"Alcohol Alcohol"},{"key":"e_1_3_2_370_1","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.25586"},{"key":"e_1_3_2_371_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<217::AID-JMV13>3.0.CO;2-H"},{"key":"e_1_3_2_372_1","first-page":"533","article-title":"EASL International Consensus Conference on Hepatitis","volume":"38","author":"The EASL Jury","year":"2003","unstructured":"The EASL Jury. EASL International Consensus Conference on Hepatitis. Consensus statement (short version). J Hepatol 2003; 38: 533\u2013540","journal-title":"Consensus statement (short version). J Hepatol"},{"key":"e_1_3_2_373_1","unstructured":"The World Bank. World Development Report 1993. Investing in Health Washington DC. The World Bank 75 1993"},{"key":"e_1_3_2_374_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360726"},{"key":"e_1_3_2_375_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322202"},{"key":"e_1_3_2_376_1","unstructured":"Torriani F J Rockstroh J Rodriguez-Torres M Lissen E Gonzalez J Lazzarin A Carosi G. Final Results of APRICOT: a randomized partially blinded international trial evaluating peginterferon-alfa-2a-ribavirin versus interferon-alfa-2a-ribavirin in the treatment of HCV in HIV-HCV co-infection. Abstract 112 11th Conference on Retroviruses and Opportunistic Infections San Francisco CA February 8\u2013112004"},{"key":"e_1_3_2_377_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.430"},{"key":"e_1_3_2_378_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282501"},{"key":"e_1_3_2_379_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00413.x"},{"key":"e_1_3_2_380_1","volume-title":"The New Havard Guide to Psychiatry","author":"Vaillant G E","year":"1988","unstructured":"Vaillant G E. The alcohol dependent and drug dependent person. The New Havard Guide to Psychiatry, A M Nicoli. Cambridge: Havard University Press. 1988"},{"key":"e_1_3_2_381_1","first-page":"1026","article-title":"Vitamin B6 metabolism in chronic alcohol abuse","volume":"55","author":"Vech R L","year":"1975","unstructured":"Vech R L, Lumeng L, Li T K. Vitamin B6 metabolism in chronic alcohol abuse. The effect of ethanol oxidation on hepatic pyridoxal 5\u2032-phosphate metabolism. J Clin Invest 1975; 55: 1026\u20131032","journal-title":"The effect of ethanol oxidation on hepatic pyridoxal 5\u2032-phosphate metabolism. J Clin Invest"},{"key":"e_1_3_2_382_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098279"},{"key":"e_1_3_2_383_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36924"},{"key":"e_1_3_2_384_1","first-page":"1","article-title":"Evidence-based recommendation on the management of HIV AIDS: an Experts' Consensus meeting to develop treatment guidelines for developed nations","author":"Volberding P","year":"1999","unstructured":"Volberding P. Evidence-based recommendation on the management of HIV AIDS: an Experts' Consensus meeting to develop treatment guidelines for developed nations. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 1\u201317","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"e_1_3_2_385_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-6-199409150-00001"},{"key":"e_1_3_2_386_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00022"},{"key":"e_1_3_2_387_1","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.895.280"},{"key":"e_1_3_2_388_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)24008-6"},{"key":"e_1_3_2_389_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1980.00500600075016"},{"key":"e_1_3_2_390_1","first-page":"76","article-title":"Wasting syndrome in AIDS: pathophysiologic mechanisms and approaches","volume":"4","author":"Weinroth S E","year":"1995","unstructured":"Weinroth S E, Parenti D M, Simon G L. Wasting syndrome in AIDS: pathophysiologic mechanisms and approaches. Infect Agents Dis 1995; 4: 76\u201394","journal-title":"Infect Agents Dis"},{"issue":"1","key":"e_1_3_2_391_1","first-page":"9","article-title":"Safety profile of interferon alpha therapy","volume":"25","author":"Weiss K","year":"1998","unstructured":"Weiss K. Safety profile of interferon alpha therapy. Semin Oncol 1998; 25(1 Suppl.)9\u201313","journal-title":"Semin Oncol"},{"key":"e_1_3_2_392_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00356.x"},{"key":"e_1_3_2_393_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198102053040602"},{"key":"e_1_3_2_394_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280330"},{"key":"e_1_3_2_395_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341107"},{"key":"e_1_3_2_396_1","volume-title":"Injuries, and Causes of Death. Ninth revision","author":"World Health Organization (WHO)","year":"1977","unstructured":"World Health Organization (WHO). International Classification of Diseases. Injuries, and Causes of Death. Ninth revision. World Health Organization, GenevaSwitzerland 1977; I and II"},{"key":"e_1_3_2_397_1","volume-title":"International Statistical Classification of Diseases and Related Health Problems10th Revision","author":"World Health Organization (WHO)","year":"1992","unstructured":"World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems10th Revision. World Health Organization, GenevaSwitzerland 1992"},{"key":"e_1_3_2_398_1","first-page":"1","volume-title":"United Nations Children's Fund (UNICEF), and the International Council for the Control of Iodine Deficiency Disorders","author":"World Health Organization (WHO)","year":"1993","unstructured":"World Health Organization (WHO). United Nations Children's Fund (UNICEF), and the International Council for the Control of Iodine Deficiency Disorders. WHO, GenevaSwitzerland 1993; 1\u20137, Global prevalence of Iodine Deficiency Disorders.\u201d Micronutrient Deficiency Information System Working Paper No. 1."},{"key":"e_1_3_2_399_1","first-page":"5","volume-title":"Micronutrient Deficiency Information System Working Paper no. 2","author":"World Health Organization (WHO) and the United Nations Children's Fund (UNICEF)","year":"1995","unstructured":"World Health Organization (WHO) and the United Nations Children's Fund (UNICEF). Global Prevalence of Vitamin A Deficiency. Micronutrient Deficiency Information System Working Paper no. 2. WHO, GenevaSwitzerland, WHO 1995; 5"},{"key":"e_1_3_2_400_1","first-page":"51","volume-title":"Conquering Suffering, Enriching Humanity","author":"World Health Organization (WHO)","year":"1997","unstructured":"World Health Organization (WHO). The World Health Report 1997. Conquering Suffering, Enriching Humanity. GenevaSwitzerland 1997; 51"},{"issue":"10","key":"e_1_3_2_401_1","first-page":"65","article-title":"Hepatitis C","volume":"72","author":"World Health Organization (WHO)","year":"1997","unstructured":"World Health Organization (WHO). Hepatitis C. Weekly Epidemiol Rec 1997b; 72(10)65\u201369","journal-title":"Weekly Epidemiol Rec"},{"issue":"1","key":"e_1_3_2_402_1","first-page":"35","article-title":"Global surveillance and control of hepatitis C","volume":"6","author":"World Health Organization (WHO)","year":"1999","unstructured":"World Health Organization (WHO). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999; 6(1)35\u201339","journal-title":"Report of a WHO Consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat"},{"key":"e_1_3_2_403_1","volume-title":"The World Health Report. Health Systems: Improving Performance. Geneva, Switzerland: World Health Organization","author":"World Health Organization (WHO)","year":"2000","unstructured":"World Health Organization (WHO). The World Health Report. Health Systems: Improving Performance. Geneva, Switzerland: World Health Organization. 2000"},{"key":"e_1_3_2_404_1","volume-title":"Reducing Risks, promoting Healthy life","author":"World Health Organization (WHO)","year":"2002","unstructured":"World Health Organization (WHO). World Health Report 2002. Reducing Risks, promoting Healthy life. World Health Organization, GenevaSwitzerland 2002"},{"key":"e_1_3_2_405_1","volume-title":"Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. from","year":"2001","unstructured":"Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. from. 2001, http:\/\/www.aidsinfo.nih.gov accessed December 14"},{"key":"e_1_3_2_406_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90269-B"},{"issue":"9","key":"e_1_3_2_407_1","first-page":"1318","article-title":"Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users","volume":"116","author":"Wu N","year":"2003","unstructured":"Wu N. Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users. Chinese Med J [in English] 2003; 116(9)1318\u20131320","journal-title":"Chinese Med J [in English]"},{"issue":"1","key":"e_1_3_2_408_1","first-page":"10","article-title":"Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease","volume":"17","author":"Zarski J P","year":"1993","unstructured":"Zarski J P, Thelu M A, Moulin C, Rachail M, Seigneurin J M. Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status. J Hepatol 1993; 17(1)10\u201314","journal-title":"Comparison with the HBV status. J Hepatol"},{"key":"e_1_3_2_409_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"},{"key":"e_1_3_2_410_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240510"},{"key":"e_1_3_2_411_1","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/642707"},{"key":"e_1_3_2_412_1","first-page":"147","volume-title":"In. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver2nd","author":"Zimmerman H J","year":"1999","unstructured":"Zimmerman H J. Hepatotoxic effects of ethanol. In. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver2nd. Lippincott Williams and Wilkinsm, Philadelphia 1999; 147\u2013177"},{"key":"e_1_3_2_413_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-194704000-00002"},{"key":"e_1_3_2_414_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80205-0"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826080600846235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:00:53Z","timestamp":1770418853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826080600846235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":413,"journal-issue":{"issue":"10-12","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1080\/10826080600846235"],"URL":"https:\/\/doi.org\/10.1080\/10826080600846235","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}